Azienda Ospedaliera San Camillo Forlanini /ID# 155628

Rome, Roma 00149

0 studies enrolling now · 1 studies all time

What they study most

Ulcerative Colitis (UC)

Studies at this site

• A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis — Running, not enrolling